Market Place
Sourcing Support
MEDiC Life Announces Collaboration with Hanmi Pharmaceutical
14 Oct 2024 //
BUSINESSWIRE
MEDiC Life Sciences Secures $5M From LG And Hanmi For Cancer
14 Oct 2024 //
BUSINESSWIRE
GC Biopharma, Hanmi Pharma Get FDA IND Clearance for Phase 1/2 Trial
03 Sep 2024 //
PR NEWSWIRE
Hanmi Collaborates with MSD to Evaluate BH3120 + KEYTRUDA Combo
23 Apr 2024 //
PR NEWSWIRE
Hanmi Pharmaceutical`s Combination Drug for Dyslipidemia Treatment, `Rosuzet`
17 Mar 2023 //
PR NEWSWIRE
FDA hands Hanmi’s partner, Spectrum, a poziotinib CRL for supplementary data
25 Nov 2022 //
KOREABIOMED
Hanmi to start confirmatory NSCLC trial of poziotinib in Korea
17 Aug 2022 //
KOREABIOMED
Hanmi relaunches liver drug after boosting bioavailability
13 Jul 2022 //
FIERCEPHARMA
Drugmakers release sustainability reports to prepare for ESG evaluation
16 Jun 2022 //
KOREABIOMED
Hanmi Fine Chemical Launches CDMO Business
27 May 2022 //
CONTRACTPHARMA
Hanmi, LG Chem, Yuhan race to develop new obesity drug
23 May 2022 //
KOREABIOMED
Hanmi Fine Chemical Launches `high-tech CDMO` Business
22 May 2022 //
BIOSPACE
Hanmi`s acute myeloid leukemia treatment named orphan drug in US
10 May 2022 //
KOREABIOMED
Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharma
04 Jan 2022 //
BUSINESSWIRE
Hanmi transfers rights for retinal disease drug to Chinese partner
03 Jan 2022 //
KOREABIOMED
Foreign partners hurry to commercialize Hanmi’s new anticancer drugs
10 Nov 2021 //
KOREABIOMED
S. Korea‘s mRNA vaccine consortium gets two new members
09 Sep 2021 //
KOREAHERALD
Hanmi’s T2D drug curbs cardiovascular, kidney issues
28 Jun 2021 //
FIERCEBIOTECH
FDA postpones approval of Hanmi Pharmaceutical’s novel breast cancer treatment
02 Mar 2021 //
KOREAHERALD
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
18 Jan 2021 //
PRESS RELEASE
Korean firm presents solution package for coping with COVID-19
12 Jan 2021 //
BIOSPECTRUMASIA
Hanmi wins suit against Lilly over drug price cut
27 Nov 2020 //
KOREABIOMED
Merck & Hanmi to develop, commercialise therapy for NASH
11 Aug 2020 //
BIOSPECTRUMASIA
Merck and Hanmi Enter into Licensing Agreement to Develop Efinopegdutide
04 Aug 2020 //
PRESS RELEASE
FDA grants fast track status to Hanmi’s investigational fatty liver med
16 Jul 2020 //
PULSENEWS
Hanmi may sue Sanofi for withdrawing from diabetes drug research
14 May 2020 //
THEINVESTOR
Hanmi Pharm and GC Green Cross Team Up to Develop New Therapy for LSD
28 Feb 2020 //
BUSINESSKOREA.CO.KR/NEWS/ARTICLEVIEW
Hanmi Pharma to develop innovative drugs for rare diseases
15 Jan 2020 //
BIOSPECTRUM ASIA
Rapt edges into Asia with Hanmi I-O deal worth up to $118M
03 Dec 2019 //
FIERCE BIOTECH
RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia
03 Dec 2019 //
GLOBENEWSWIRE
Innovent Biologics begins phase I trial of anti-PD-1/HER2 bispecific antibody
27 Nov 2019 //
PHARMABIZ
Is the future of diabetes treatment better drugs or better care?
23 Sep 2019 //
BIOPHARMADIVE
Innovent Update on Results of IBI305 on Non-squamous Cell Lung Cancer
19 Sep 2019 //
BIOSPACE
Hanmi crashes after J&J drops diabetes candidate
06 Jul 2019 //
THE PHARMALETTER
Janssen hands back rights to Hanmi`s diabetes/obesity drug
05 Jul 2019 //
PHARMATIMES
Lilly cuts a trio of pipeline assets, including BTK inhibitor, diabetes drug
07 Feb 2019 //
FIERCE BIOTECH
Pfizer strives to save blockbuster anti-smoking drug
29 May 2018 //
KOREABIOMED
After patient deaths, failed partnerships & scandal, Hanmi gives up olmutinib
14 Apr 2018 //
ENDPTS
Hanmi Pharma gives up on development of lung cancer drug Olita
12 Apr 2018 //
KOREAHERALD
Hanmi Mulls New Trial Strategy As ZAI Lab Ends Olmutinib Partnership
02 Apr 2018 //
PHARMAINTELLIGENCE
Hanmi Pharma betting on ‘smart plant’ in move toward CDMO
29 Mar 2018 //
FIERCE PHARMA
Lilly drops Hanmi-partnered arthritis drug
20 Feb 2018 //
PMLIVE
Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi
20 Feb 2018 //
ENDPTS
Top Korean pharma companies increase their R&D spending in H1
16 Aug 2017 //
BIOSPECTRUM
Hanmi Pharm`s Esomezol listed in US drug encyclopedia
18 Jul 2017 //
KOREAHERALD
China pharma market prospect, Hanmi’s negligence, Celgene’s
21 Apr 2017 //
FIERCE PHARMA
Hanmi hit over failure to disclose olmutinib cancer trial side effect
18 Apr 2017 //
FIERCE BIOTECH
Hanmi to globally launch dual-action hyperlipidemia drug with MSD
03 Jan 2017 //
KOREA HERALD
Work on Another Sanofi Drug Delayed by Manufacturing Issues
09 Nov 2016 //
FIERCE PHARMA
South Korea`s Hanmi Pharmaceuticals in Troubled Waters!
15 Oct 2016 //
BIOSPECTRUM ASIA
Boehringer backs out of $730M lung cancer pact with Hanmi following data review
01 Oct 2016 //
FIERCE BIOTECH
Hanmi Pharma, Genentech ink exclusive license pact to develop pan-RAF HM95573
30 Sep 2016 //
PHARMABIZ
Next in a String of Deals, Korea’s Hanmi Pharma Inks $910M Deal with Genentech
29 Sep 2016 //
BIOSPACE
Korea`s Hanmi inks deal with Roche`s Genetech
04 Sep 2016 //
BIOSPECTRUM
Boehringer Bails On Hanmi Lung Cancer Deal
03 Sep 2016 //
PHARMAMANUFACTURING
South Korea’s Hanmi Pharma starts sales of locally developed NSCLC drug
23 May 2016 //
FIERCE PHARMA ASIA
Hanmi Pharma obtains indian patent on esomeprazole strontium
18 May 2016 //
TWO FOUR INSIGHT
Asia`s lung cancer burden
13 Apr 2016 //
BIOSPECTRUM ASIA
South Korea approved more clinical trials in 2015
26 Feb 2016 //
FIERCE PHARMA ASIA
